Three Bridge Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Three Bridge Wealth Advisors's NVO Position: Q3 2026 in Review
Three Bridge Wealth Advisors reduced its Novo Nordisk (NVO) stake by 0.5% in Q3 2026, selling an estimated $13K and leaving 56,451 shares worth $2.14M. The position accounts for 0.46% of the portfolio, ranked #30.
Three Bridge Wealth Advisors first reported a position in NVO in Q1 2022 and has held it in 19 quarters since. The position peaked at $2.72M in Q2 2026. 1,061 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Three Bridge Wealth Advisors held 56,451 shares of Novo Nordisk worth $2.14M as of Q3 2026.
- Three Bridge Wealth Advisors sold 282 Novo Nordisk shares in Q3 2026, an estimated $13K.
- Novo Nordisk made up 0.46% of Three Bridge Wealth Advisors's portfolio in Q3 2026, its #30 holding.
- Three Bridge Wealth Advisors first reported a position in Novo Nordisk in Q1 2022 and has held it in 19 quarters since.
- Three Bridge Wealth Advisors's Novo Nordisk position peaked at $2.72M in Q2 2026.
- 1,061 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Three Bridge Wealth Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.